ABBOTT LABORATORIES EVP and CFO Philip P. Boudreau forfeited 388 shares at $110.36 per share, leaving him with 70,784 shares after the transaction. The disclosed ownership figure gives investors a precise view of Boudreau’s remaining Abbott Equity position following the Sep. 1, 2026 transaction.

Key Highlights

  • Philip P. Boudreau serves as ABBOTT LABORATORIES’ executive vice president and chief financial officer.
  • Each forfeited share carried a reported value of $110.36.
  • According to the filing, Philip Boudreau forfeited 388 ABBOTT LABORATORIES shares in the reported transaction.

ABBOTT LABORATORIES (NYSE: ABT) executive vice president and chief financial officer Philip P. Boudreau forfeited 388 shares at $110.36 per share, leaving him with 70,784 shares after the transaction. The transaction occurred on Sep. 1, 2026.

Abbott CFO’s Remaining Equity Position

Boudreau’s post-transaction ownership stood at 70,784 ABBOTT LABORATORIES shares. The reported transaction involved 388 shares. Each share was valued at $110.36. Philip P. Boudreau holds the company’s executive vice president and chief financial officer roles.